Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
As of August 25, 2003, this controversial paper had generated 85 Rapid Responses, which can be read in their entirety at http://bmj.com/cgi/eletters/326/7404/1419. Following are edited excerpts Editor
| The first 150 words of the full text of this article appear below. |
From BMJ USA 2003;September:481
Editor I am just wondering if the "compelling" observational evidence that lowering serum homocysteine reduces heart disease is as "compelling" as the observational evidence that estrogen did the same thing.
William E Osmun, assistant profession
University of Western Ontario, Mount Brydges, Canada. wosmun@uwo.ca
Editor Even in "high risk" populations, statins failed to reduce overall mortality in ALLHAT, PROSPER and ASCOT while the number needed to treat for 1 year to postpone 1 death in HPS was about 300. These are the last 12 months of statin trials. The concept of all-cause mortality is glaringly missing in the Wald and Law analysis.
Eddie Vos, maintains www.health-heart.org
Sutton, Canada. vos@health-heart.org
Editor I have read some rubbish in my time, but this just about takes the biscuit. Let's take this to its logical conclusion and put every drug known to medical science in the water supply. That way we will prevent and cure every disease humanity is subject to.
Or, of course, we could cut mortality
Barry A Groves, independent researcher
barry@second-opinions.co.uk
Eugene A Rybinski, general practitioner
Sheffield, UK. erybinski@compuserve.com
Ewan Hamnett, GP principal
Birmingham, UK. mandy.goldstein@bhamchildrens.wmids.nhs.uk
Paul W Masters, consultant chemical pathologist
Chesterfield Royal Hospital, UK. paul.masters@chesterfieldroyal.nhs.uk
Anita Sainsbury
St James's University Hospital, Yorkshire, UK. anitabansal@yahoo.com
David M Reith, senior lecturer
Dunedin School of Medicine, University of Otago, Dunedin, New Zealand. david.reith@stonebow.otago.ac.nz
Tom Fahey, professor of primary care medicine
t.p.fahey@dundee.ac.uk
Alan Montgomery, Yoav Ben Shlomo
University of Dundee, UK
Derek Yach, executive director
yachd@who.int
Shanthi Mendis, JoAnne Epping, Ruth Bonita, Amalia Waxman
Noncommunicable Diseases & Mental Health, World Health Organization
Gerry E Burns, GP principal
Belfast, UK. g.burns@p060.gp.n-i.nhs.uk